Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124281604 | 12428160 | 4 | F | 20151009 | 20160831 | 20160602 | 20160905 | EXP | CA-ROCHE-1647687 | ROCHE | 48.09 | YR | F | Y | 0.00000 | 20160905 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124281604 | 12428160 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2047,B2035,N3722 | 125276 | 256 | MG | SOLUTION FOR INFUSION | |||||||
| 124281604 | 12428160 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | DAY 1, 15 (1ST RPAP DOSE) | B2047,B2035,N3722 | 125276 | SOLUTION FOR INFUSION | ||||||||
| 124281604 | 12428160 | 3 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | DAY 1 15 | 103705 | 1000 | MG | ||||||||
| 124281604 | 12428160 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | DAY 1 15 | 103705 | 1000 | MG | ||||||||
| 124281604 | 12428160 | 5 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 124281604 | 12428160 | 6 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
| 124281604 | 12428160 | 7 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 0 | ||||||||||||
| 124281604 | 12428160 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 124281604 | 12428160 | 9 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 124281604 | 12428160 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124281604 | 12428160 | 1 | Rheumatoid arthritis |
| 124281604 | 12428160 | 3 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124281604 | 12428160 | HO |
| 124281604 | 12428160 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124281604 | 12428160 | Abdominal pain | |
| 124281604 | 12428160 | Blister | |
| 124281604 | 12428160 | Chest discomfort | |
| 124281604 | 12428160 | Chest pain | |
| 124281604 | 12428160 | Facial pain | |
| 124281604 | 12428160 | Headache | |
| 124281604 | 12428160 | Heart rate decreased | |
| 124281604 | 12428160 | Hypotension | |
| 124281604 | 12428160 | Nausea | |
| 124281604 | 12428160 | Neutropenia | |
| 124281604 | 12428160 | Neutrophil count decreased | |
| 124281604 | 12428160 | Oropharyngeal pain | |
| 124281604 | 12428160 | Pain | |
| 124281604 | 12428160 | Pain of skin | |
| 124281604 | 12428160 | Pruritus | |
| 124281604 | 12428160 | Skin swelling | |
| 124281604 | 12428160 | Swelling face | |
| 124281604 | 12428160 | Tooth infection | |
| 124281604 | 12428160 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124281604 | 12428160 | 1 | 20151008 | 20160510 | 0 | |
| 124281604 | 12428160 | 2 | 20090724 | 0 | ||
| 124281604 | 12428160 | 3 | 2006 | 20140825 | 0 | |
| 124281604 | 12428160 | 4 | 20150724 | 0 | ||
| 124281604 | 12428160 | 5 | 20090724 | 20140825 | 0 | |
| 124281604 | 12428160 | 9 | 20090724 | 20140825 | 0 | |
| 124281604 | 12428160 | 10 | 20090724 | 20140825 | 0 |